We recently provided evidence that interleukin-15 (IL15) is lowly expressed in the pig adipocyte, and that interferon (IFN ) markedly increases this expression through a pathway regulated in part by protein kinase C (PKC). In the present study, we tested the hypothesis that IL15 acts directly on the adipocyte to regulate lipid accretion by enhancing lipolysis or suppressing lipogenesis. Using recombinant porcine IL15, we determined that this cytokine stimulates lipolysis in a dose-dependent manner (P< 0.001). Furthermore, comparative studies with other cytokines showed that IL15 is more potent in its acute stimulation of lipolysis than either TNF or IL6, lipopolysaccharide (P< 0.001). When specific inhibitors of protein kinase A (PKA) or Janus kinase (JAK) are present, the lipolytic effect of IL15 is attenuated (P<0.01).
Introduction
Interleukin-15 is highly expressed in skeletal muscle, and has been shown to exert a powerful anabolic effect on muscle protein accretion (16, 17) . In addition to its enhancement of muscle growth, there is also evidence that IL15 suppresses fat accretion in rodent models, perhaps through a direct effect on the adipocyte. Recently, Alvarez et al. (3) provided conclusive evidence of the expression of the IL15 receptor in adipose tissue of rodents. Furthermore, the reduction in adiposity achieved with IL15 in lean Zucker rats was precluded in fa/fa rats in which adipose expression of the (c) signaling receptor subunit is also markedly lower than in lean controls. Consequently, these investigators suggested that the effect of IL15 on adipose mass was indeed a direct effect on the adipocyte.
We have recently demonstrated that IL15 expression is strongly up-regulated in primary porcine adipocytes treated with IFN (2) . Because the latter cytokine is a major inflammatory mediator (8, 24) , it is plausible that its induction of IL15 is a component of the acute phase response which facilitates the mobilization and repartitioning of energy away from the adipocyte to support other immediate needs. Albeit, there is currently no evidence that IL15 acts directly on the adipocyte to alter lipogenesis or lipolysis, the major processes by which lipid storage and release in the adipocyte are regulated. Consequently, the experiments reported herein were designed to test the hypothesis that IL15 acts directly on the adipocyte to enhance lipolysis and suppress lipogenesis. Additionally, we sought to identify specific steps in the pathways by which IL15 exerts these effects.
Materials and Methods
Adipocyte isolation. Adipocytes from subcutaneous fat depot of castrate male pigs weighing 4 were diluted to approximate 20% cell suspensions with DMEM (Sigma, St. Louis, MO) containing 3% fatty acid-free serum albumin. The cell suspensions were gassed initially and at 2-hour intervals with a mixture of air and CO 2 and were incubated in a gyratory floor incubator at 37°C for the selected duration. Reactions were terminated by allowing adipocytes to float on the surface, and carefully aspirating the medium from the bottom of the vials. The medium was assayed for glycerol using the Triglyceride reagent from Sigma (Sigma, St Louis) and data expressed as µg/mL. The rate of lipogenesis was determined as the as the incorporation of [U-14C] glucose into fatty acids as described by Liu et al., 1989 . Briefly, cells were incubated for 2 hours in the presence of .5 µCi of 14 C glucose. Samples were processed as described previously, and rates are expressed as pmol/min.
To study intracellular kinases involved in IL15 action, adipocytes were pretreated for 1- Statistical analyses. All data were examined for normality and analyzed with the mixedmodel analysis of a split-plot design. The fixed effect was the treatment, and the random effect was the replicate (pig). The main effects (treatment and replicate) were tested against the treatment x replicate interaction. When protected by a significant F-test, mean separation was accomplished using the least-squares mean separation (pdiff) procedure (20) . lipid, but the magnitude of the suppression was only 5-7 % versus controls (data not shown).
Results

IL15 stimulates lipolysis in a dose
Discussion
Interleukin-15 is a 14-kDa member of the 4 helix bundle family of cytokines, which communicate immunological needs to T-cell and natural killer cell populations (19, 18) . Though a clear participant in immune modulation cascades, this cytokine is highly expressed in skeletal muscle (21, 22) , where it promotes protein accretion (17) and antagonizes muscle wasting in some disease models (7). We recently demonstrated that low-level IL15 expression is markedly up-regulated in pig adipocytes treated with IFN (2), the latter cytokine being a major mediator of inflammation in pigs (8) . Based on this finding, and on the indications that IL15 might act directly on the adipocyte to regulate fat accretion (3), we hypothesized that IL15 would enhance lipolysis and suppress lipogenesis. Indeed, the evidence presented indicates that IL15 does target the adipocyte directly, and in an acute manner, to transiently stimulate lipolysis and suppress lipogenesis. The concentrations of IL15 used in our experiments are higher than in the systemic circulation (11, 9), but secretion of IL15 by the adipocyte may present these cells with substantially higher concentrations than is reflected in the circulation. The anti-lipogenic effect of IL15 was quite small, and its biological significance is unclear. The small attenuation achieved after 2 hours may have a greater impact in vivo, but longer term experiments will be required to address this issue.
Collectively, these findings indicate a potential autocrine regulatory axis in which IL15 is induced by IFN , with the metabolic effects of mobilizing fatty acids for use as energy or as precursors to signaling molecules such as diacyl glycerol or phosphoinositides. Although it will be necessary to confirm that the IL15 protein is actually synthesized and released by the adipocyte before the evidence of such an autocrine loop will be conclusive, it is already apparent that serum IL15 is elevated in many inflammatory states (11, 9) . Thus, the adipocyte may contribute to the increased circulating concentrations. 
